Swiss National Bank’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-101,150
Closed -$1.64M 2764
2022
Q1
$1.64M Buy
101,150
+16,200
+19% +$415K ﹤0.01% 2142
2021
Q4
$4.03M Buy
84,950
+11,500
+16% +$690K ﹤0.01% 1603
2021
Q3
$5.32M Hold
73,450
﹤0.01% 1419
2021
Q2
$6.17M Buy
+73,450
New +$4.85M ﹤0.01% 1342

Other funds holding NBP

Swiss National Bank's NBP Position: Q2 2022 in Review

Swiss National Bank sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 101,150 shares — an estimated $1.64M sold.

Swiss National Bank first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $6.17M in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Swiss National Bank reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 101,150 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $1.64M.
  • Swiss National Bank first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
  • Swiss National Bank's NovaBridge Biosciences American Depositary Shares position peaked at $6.17M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.